IMVT-1401-2401: Phase 2b Study to Assess Efficacy and Safety of Batoclimab in Adult Participants with Active CIDP. (clinicaltrialsregister.eu) - May 11, 2026 - P1/2 | N=178 | Completed | Sponsor: Immunovant Sciences GmbH | Suspended ➔ Completed
Trial completion • Pain
|